Author: TroyFlowers

02-28-2018 Video News – The Marijuana Times Show

Joe Klare discusses what some lawmakers in New Jersey are being told about cannabis, new ID compliance numbers for marijuana retailers out of Oregon and Colorado Governor John Hickenlooper’s thoughts on Jeff Sessions and legalization. 02-28-2018 – Ep. 83 | Marijuana Times Show https://www.marijuanatimes.org/new-jerseys-legislative-black-caucus-told-of-dire-consequences-of-marijuana-legalization-in-hearing/ http://www.statesmanjournal.com/story/news/2018/02/22/fewer-pot-retailers-caught-selling-marijuana-minors-oregon-stings/365326002/ http://thehill.com/podcasts/hillcast/375336-listen-colorado-governor-says-doj-wants-to-sow-doubt-on-marijuana Sponsor: http://naturecidecannabis.com/ TroyFlowers Author description...

Read More

Earth Science Tech, Inc. Finalizes Plans for Human Trials on New CBD-Based Formula Targeting Opioid Addiction Epidemic

SHARE THIS POST DORAL, Fla., Feb. 28, 2018 (GLOBE NEWSWIRE) — via NetworkWire – Earth Science Tech, Inc. (OTC:ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabinoid (CBD), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announces that it has finalized the plans for its previously announced human trial to assess the efficacy of the combination of an essential mineral element and full-spectrum cannabinoid industrial hemp oil. The purpose of this nine-month trial is to develop a CBD formulation and methodology for treating opioid addicts, preventing fatal overdoses, and relieving side-effects from withdrawals. This formulation is expected to increase potency as opposed to the current status quo, which consists solely of essential mineral element therapy (monotherapy) in treating patients with morbid substance abuse and/or dependence.Globally, there are numerous, promising clinical studies on the potential of cannabinoids for the treatment of substance abuse and psychological disorders. ETST’s new study takes advantage of two of the properties of the Company’s full-spectrum cannabinoids industrial hemp oil that, based on positive feedback from customers and doctors, have demonstrated great success against addiction. ETST’s cannabinoids will be mixed with an essential mineral element, thereby potentially supporting and increasing the action of other drugs and medicinal substances. The human trial will study substance abuse patients who have undergone drug prescription treatment or dietary supplement monotherapy,...

Read More

Maricann Provides Equity Financing Update

SHARE THIS POST Special Committee of Independent Directors Reviewing Trading Activity by Maricann Directors and Matters Involving its Chief Executive Officer Raymond Stone and Neil Tabatznik Resign As Directors Paul Pathak Appointed Interim Chairman of the Board TORONTO, Ontario, February 28, 2018 – Maricann Group Inc. (CSE:MARI, OTCQB:MRCCF, FRANKFURT:75M, “Maricann” or the “Company”) announced today that it has been advised orally by the underwriters that they are not prepared to proceed with the previously announced bought deal offering of 17,500,000 units of the Company, for gross proceeds of $70,000,000 (the “Offering”). The Company has not received an official notice of termination of the Offering. The Company also announces the resignations of Raymond Stone and Neil Tabatznik as directors and the appointment of Paul Pathak as interim chairman of the board. The Company also announced that the Ontario Securities Commission (“OSC”) has advised it that the OSC is conducting a review of the timing and reporting of certain trades in securities of the Company beneficially owned, directly or indirectly, or over which control or direction is exercised by Messrs. Stone and Tabatznik and Eric Silver or their respective associates and affiliates or by other persons otherwise directly or indirectly related to them, as the case may be, that were effected prior to the announcement of the Offering. Messrs. Stone, Tabatznik and Silver have advised the Company that they are fully...

Read More

Harvest One Launches Retail Platform and Completes Initial Sales

SHARE THIS POST VANCOUVER, Feb. 28, 2018 /CNW/ – Harvest One Cannabis Inc. (TSXV:HVT) (“Harvest One” or the “Company”) through its wholly-owned subsidiary United Greeneries (“United Greeneries” or “UG”) is pleased to announce the launch of its retail platform and initial sales of their two brands Royal High and Captain’s Choice. As previously announced on January 8, 2018, United Greeneries has launched medical sales in February 2018. The fully developed branding was released earlier this week and the fully functional e-commerce platform is currently online. Please visit United Greeneries website at www.unitedgreeneries.com for further information on our products. Captain’s Choice™ United Greeneries signature product line Captain’s Choice™ consists of blended, high-quality ground flowers. Captain’s Choice™ will be available in the varieties “Indica”, “Sativa” and “High-CBD”. United Greeneries’ specialized blending and grinding process results in consistent product quality and reduced production costs that the Company will be passing on to its customers. Royal High™ The Company’s premium brand Royal High™ will feature prime quality full cannabis flowers of selected varieties, initially consisting of Serious Kush, Great White Shark, Super Skunk, 8 Ball Kush, CBD Tonic, Serious Kush, Northern Lights and Chocolope. Several other varieties are currently in production. About Harvest One Cannabis Inc. (TSXV: HVT) Harvest One is a global cannabis company focused on delivering high quality, innovative cannabis products and technology to regulated markets around the world. Our shareholders...

Read More

ABcann Global Completes $70 Million Bought Deal Financing and $4.8 Million Exercise of Underwriters’ Over-Allotment Option

SHARE THIS POST NAPANEE, Ontario, Feb. 28, 2018 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV:ABCN) (“ABcann” or the “Company”) is pleased to announce that it has closed its bought deal financing, as previously announced on January 29, 2018, of: (i) 11,500,000 units (each, a “Unit”) of the Company at a price of $3.50 per Unit, for aggregate gross proceeds of $40,250,000 (the “Unit Offering”); and (ii) 30,000 6.0% unsecured convertible debentures (each, a “Convertible Debenture”) of the Company at a price of $1,000 per Convertible Debenture, for aggregate gross proceeds of $30,000,000 (the “Debenture Offering” and collectively with the Unit Offering, the “Offering”). The Offering was conducted by a syndicate of underwriters led by Canaccord Genuity Corp. and Eight Capital and including GMP Securities L.P. and PI Financial Corp. (collectively, the “Underwriters”). In addition, the Offering included 862,500 Warrants (defined below) and 4,500 Convertible Debentures sold pursuant to the exercise of the Underwriters’ over-allotment option, for additional aggregate gross proceeds of $4,793,250. “Completion of the Offering further increases our cash position to over $135 million and will allow us to pursue multiple opportunities and execute our strategic vision,” stated Barry Fishman, ABcann’s Chief Executive Officer.The Units and the Convertible Debentures were offered by way of a short form prospectus (the “Prospectus”) in all provinces of Canada except Quebec. The net proceeds of the Offering will be used for the...

Read More

GrowLife, Inc. Files Provisional Patent on Plant Waste Manufacturing Process as Part of Product Innovation and Sustainable Solutions Initiative

SHARE THIS POST As U.S. states shift in favor of cannabis legalization, industry leader in indoor cultivation products innovates solution for 80% of plant materials currently going to waste KIRKLAND, Wash.–(BUSINESS WIRE)– GrowLife, Inc. (PHOT) (“GrowLife”), one of the nation’s most recognized indoor cultivation service and product providers, today announced that it has filed a provisional patent with the U.S. Patent and Trademark Office (USPTO), through its wholly owned subsidiary GrowLife Innovations, on an novel process to repurpose waste plant materials into building materials and other products for use in indoor cultivation centers. The patent, which specifically addresses waste materials from plants of the cannabis family following extraction of oils used to make consumer products, provides for a process of manufacturing left-behind fibrous plant materials into polymer composites. A commonly known fiber-reinforced composite is fiberglass, among many others. “This proprietary process will provide the entire industry with a sustainable solution to a problem that is only going to get worse as demand for plant-based products increases which has barely been identified and will have a huge impact on profitability of cultivators in the future,” said Marco Hegyi, CEO of GrowLife. “Cultivators are being held responsible for disposal of these used plant materials at a great cost to them with little to no options for reuse of the materials. This patent will help us to continue to meet the needs...

Read More